NFKB1 and type 2 diabetes mellitus: Notably, mechanistic studies utilizing MSCs derived from patients with atherosclerosis and type 2 diabetes mellitus (T2DM) have provided crucial insights into NF-κB-mediated immunoregulatory pathways (109).